Neurodevelopmental Outcomes after Intravitreal Bevacizumab Therapy for ROP
85 بار بازدید -
5 سال پیش
-
At the mean age of
At the mean age of 1.5 years, children with prior history of IVB (group 2) showed similar refractive and visual outcomes and similar neurodevelopmental outcomes compared with premature patients with ROP without requirement of treatment (group 1), although there is a possibility that a small but clinically significant difference may not have been detected in the current study
5 سال پیش
در تاریخ 1398/11/12 منتشر شده
است.
85
بـار بازدید شده